| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/2007 | WO2007011711A2 Paramyxoviridae virus preparations |
| 01/25/2007 | WO2007011698A2 Humanized antibody conjugates and related methods, assays, reagents, and kits |
| 01/25/2007 | WO2007011595A2 Neural regeneration peptides and antioxidants protect neurons from degeneration |
| 01/25/2007 | WO2007011411A2 N-fragment of edema factor as an antigen for immunization against anthrax |
| 01/25/2007 | WO2007011339A1 Methods for treating and preventing brain cancers |
| 01/25/2007 | WO2007011265A1 Method for blocking noggin2 target specific activities |
| 01/25/2007 | WO2007011210A2 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/25/2007 | WO2007011044A1 Pharmaceutical composition comprising disulfide-linked hla-g dimer and process for production of disulfide-linked hla-g dimer |
| 01/25/2007 | WO2007011041A1 Genetically modified antibody composition |
| 01/25/2007 | WO2007010692A1 Pharmaceutical composition for treatment of inflammatory bowel disease which targets at hvem and btla, and therapeutic method |
| 01/25/2007 | WO2007010628A1 Prophylactic/therapeutic agent for cancer |
| 01/25/2007 | WO2007010586A1 Hematopoietic stem cell identifier |
| 01/25/2007 | WO2007010406A2 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population |
| 01/25/2007 | WO2007010291A1 Vaccine |
| 01/25/2007 | WO2007010283A1 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein |
| 01/25/2007 | WO2007010040A1 Antigen binding polypeptides against f4 (k88) fimbriae |
| 01/25/2007 | WO2007009816A2 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | WO2007009673A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 01/25/2007 | WO2007009469A2 Potency assays for antibody drug substance binding to an fc receptor |
| 01/25/2007 | WO2006131951A3 MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT |
| 01/25/2007 | WO2006131013A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 01/25/2007 | WO2006130022A8 Modulation of ovulation by agonists and antagonists of bmprii |
| 01/25/2007 | WO2006129090A3 Vaccines |
| 01/25/2007 | WO2006128715A3 Polyclonal antiserum against a universal tumor antigen |
| 01/25/2007 | WO2006125200A3 Method for reducing sepsis or cardiogenic shock associated with myocardial injury |
| 01/25/2007 | WO2006122986A3 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 01/25/2007 | WO2006117689A3 Method for diagnosing multiple sclerosis |
| 01/25/2007 | WO2006083286A3 Genetically engineered swine influenza virus and uses thereof |
| 01/25/2007 | WO2006078588A3 Improved methods for treating headache |
| 01/25/2007 | WO2006078164A3 Mycobacteria with mannose cap-deficient lipoarabinomannan |
| 01/25/2007 | WO2006076508A3 Method for producing a vaccine for the treatment of cancer |
| 01/25/2007 | WO2006071990A3 Methods to bypass cd+4 cells in the induction of an immune response |
| 01/25/2007 | WO2006039238A3 Irta2 antibodies and methods of use |
| 01/25/2007 | WO2006037048A3 Fc RECEPTOR HOMOLOG ANTIBODIES AND USES THEREOF |
| 01/25/2007 | WO2006036568A3 Antibody buffering of a ligand in vivo |
| 01/25/2007 | WO2006032475A3 Staphylococcal immunogenic compositions |
| 01/25/2007 | WO2005123128A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/25/2007 | WO2005113837A3 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 01/25/2007 | WO2005081982A3 Methods for preparing t-cells for cell therapy |
| 01/25/2007 | WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 01/25/2007 | WO2004063342A3 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 01/25/2007 | WO2004058797A3 Human monoclonal antibodies against interleukin 8 (il-8) |
| 01/25/2007 | WO2004052186A3 Expressed genes that define the osteoclast phenotype |
| 01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 01/25/2007 | US20070021377 Pharmaceutical composition comprising a macrolide immunomodulator |
| 01/25/2007 | US20070021374 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/25/2007 | US20070021373 Administering polypeptide which elicits an immune response |
| 01/25/2007 | US20070021372 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021371 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021370 Administering polypeptide which elicits immune response; antibodies useful as probes for detection; vaccines |
| 01/25/2007 | US20070021369 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021365 Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto |
| 01/25/2007 | US20070021332 Helminth-derived antigens having capacity of providing protection against parasites |
| 01/25/2007 | US20070020746 Staphylococcus aureus polynucleotides and sequences |
| 01/25/2007 | US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 01/25/2007 | US20070020685 Secretion of antibodies without signal peptides from bacteria |
| 01/25/2007 | US20070020327 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 01/25/2007 | US20070020297 System and method for the treatment of cancer, including cancers of the central nervous system |
| 01/25/2007 | US20070020296 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/25/2007 | US20070020295 Controlled release neurotoxin system and method |
| 01/25/2007 | US20070020294 Use of botulinum toxin for treatment of articular pathologies |
| 01/25/2007 | US20070020293 Vaccines against group neisseria meningitidis and meningococcal combinations thereof |
| 01/25/2007 | US20070020292 Novel method for isolating endotoxins |
| 01/25/2007 | US20070020291 Vaccines for protection from Bartonella infection and related methods of use |
| 01/25/2007 | US20070020290 Natural antibodieactive against HIV virus |
| 01/25/2007 | US20070020289 Preparations and processes for stabilizing biological materials by means of drying processes without freezing |
| 01/25/2007 | US20070020288 Vaccine |
| 01/25/2007 | US20070020287 Virulence genes of M.marinum and M. tuberculosis |
| 01/25/2007 | US20070020286 Recombinant constructs of Borrelia burgdorferi |
| 01/25/2007 | US20070020285 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 01/25/2007 | US20070020284 decreased protein degradation, increased stability and circulation time; for excess weight, diabetes, high blood lipid level, arteriosclerosis, arterial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 01/25/2007 | US20070020283 Fusion protein; multimeric protein; treating interferon gamma -related conditions |
| 01/25/2007 | US20070020282 Monoglycerides; fatty acids; for parenteral or mucosal administration of antigens and/or vaccines to humans and animals |
| 01/25/2007 | US20070020281 Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof |
| 01/25/2007 | US20070020280 Compositions and methods for inhibition of HIV-1 infection |
| 01/25/2007 | US20070020279 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 01/25/2007 | US20070020278 Diagnosing and treating cancer |
| 01/25/2007 | US20070020277 Human Oncogene Induced Secreted Protein I |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020274 Method of preventing or reducing the likelihood of pregnancy |
| 01/25/2007 | US20070020273 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/25/2007 | US20070020272 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof |
| 01/25/2007 | US20070020271 Endothelial cell specific antibodies and uses thereof |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020269 Phosphokinase and the usage thereof |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020267 monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/25/2007 | US20070020266 Gpr54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020264 Serum albumin binding peptides for tumor targeting |
| 01/25/2007 | US20070020263 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 01/25/2007 | US20070020262 Uses of mammalian cytokine: related reagents |
| 01/25/2007 | US20070020261 Combination therapy of her expressing tumors |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020259 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 01/25/2007 | US20070020258 Immunoglobulin variants |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070020256 Methods for treatment of allergic asthma |
| 01/25/2007 | US20070020255 Method of stabilizing antibody and stabilized solution-type antibody preparation |